Abstract
Objectives
We investigated the quality of life (QOL) in parents of children with late treated phenylketonuria (PKU) and its associated factors.
Methods
We conducted a cross sectional study in the reference center of inherited metabolic disease in Tunisia. We used the Tunisian version of the 36-item short-form health survey questionnaire (SF-36). We compared variables in the groups with and without impaired QOL and the SF-36 scores between subgroups of parents and children and between our sample and the Tunisian general population based on published data. We looked for associations between SF-36 scores and quantitative variables. Linear regression and logistic binary regression were used for multivariate analysis.
Results
Sixty-five parents from 42 families participated. QOL was impaired in 61% of them. The mean SF-36 score was 55.3 ± 25.07. The physical component sub-score was higher than that reported in the Tunisian general population (63.66 ± 27.77 vs. 50.11 ± 8.53; p<0.001). The mental component sub-score was comparable to that reported in the Tunisian general population (46.99 ± 25.94 vs. 47.96 ± 9.82; p=0.830). Gender (mothers) (p=0.008), low monthly income (p = 0.027), low education (p=0.011), and autism in PKU children (p = 0.001) were associated with impaired QOL.
Conclusions
We identified at risk parents for altered quality of life among parents of PKU children. Our findings were used to develop a psychological and social support strategy for at-risk parents and to promote the implementation of newborn screening of this treatable disease in our low-income country.
Acknowledgments
Authors would like to think all the participating families.
Authors’ contributions: RBA: conceptualization, methodology, formal analysis, investigation, resources, data curation, writing original draft and project administration. ABC: conceptualization, resources, review and editing. HK: investigation, data curation and writing original draft. SBM: data curation. MF: investigation, resources. ZBA: investigation, resources. YS: investigation, resources. MSA: review and editing. HA: resources, review and editing. NT: resources, supervision
Funding sources: None declared.
Informed consent: Informed consent was obtained from all individual participants included in the study.
Ethical considerations: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The ethics committee of our institution approved this study.
Conflict of interest: The authors declare that they have no conflict of interest.
References
1. Ben Dridi, MF, Ben Turkia, H, Azzouz, H, Ben Chehida, A, Ben Abdelaziz, R, Tebib, N. Inborn metabolic disorders in Tunisia: challenges, experience and hopes. Arch Pediatr 2015;22 (5 Suppl):3–4. https://doi.org/10.1016/s0929-693x(15)30003-8.Search in Google Scholar
2. Burgard, P, Lachmann, RH, Walter, J. Hyperphenylalaninaemia. In: Saudubray, J-M, Baumgartner, MR, Walter, J, editors. Inborn metabolic diseases diagnosis and treatment. Berlin, Heidelberg: Springer-Verlag 2016:251–64.10.1007/978-3-662-49771-5_16Search in Google Scholar
3. Scriver, CR, Waters, PJ, Sarkissian, C, Ryan, S, Prevost, L, Cote, D, et al. PAHdb: a locus-specific knowledgebase. Hum Mutat 2000;15:99–104. https://doi.org/10.1002/(sici)1098-1004(200001)15:1<99::aid-humu18>3.0.co;2-p.10.1002/(SICI)1098-1004(200001)15:1<99::AID-HUMU18>3.0.CO;2-PSearch in Google Scholar
4. Khemir, S, Halayem, S, Azzouz, H, Siala, H, Ferchichi, M, Guedria, A, et al. Autism in phenylketonuria patients: from clinical presentation to molecular defects. J Child Neurol 2016;31:843–9. https://doi.org/10.1177/0883073815623636.Search in Google Scholar
5. Abadie, V. Phenylketonuria, from neonatal screening to adulthood. Arch Pediatr 2007;14:607–9. https://doi.org/10.1016/j.arcped.2007.02.016.Search in Google Scholar
6. Khemir, S, El Asmi, M, Sanhaji, H, Feki, M, Jemaa, R, Tebib, N, et al. Phenylketonuria is still a major cause of mental retardation in Tunisia despite the possibility of treatment. Clin Neurol Neurosurg 2011;113:727–30. https://doi.org/10.1016/j.clineuro.2011.07.016.Search in Google Scholar
7. Scriver, CR. The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat 2007;28:831–45. https://doi.org/10.1002/humu.20526.Search in Google Scholar
8. National Institutes of Health. National Institutes of Health (NIH) to host a consensus development conference on screening and management for phenylketonuria (PKU). Pediatr Nurs 2000;26:539.Search in Google Scholar
9. Hatzmann, J, Valstar, MJ, Bosch, AM, Wijburg, FA, Heymans, HS, Grootenhuis, MA. Predicting health-related quality of life of parents of children with inherited metabolic diseases. Acta. Paediatr. 2009;98:1205–10. https://doi.org/10.1111/j.1651-2227.2009.01269.x.Search in Google Scholar
10. ten Hoedt, AE, Maurice-Stam, H, Boelen, CC, Rubio-Gozalbo, ME, van Spronsen, FJ, Wijburg, FA, et al. Parenting a child with phenylketonuria or galactosemia: implications for health-related quality of life. J Inherit Metab Dis 2011;34:391–8. https://doi.org/10.1007/s10545-010-9267-3.Search in Google Scholar
11. Mahmoudi-Gharaei, J, Mostafavi, S, Alirezaei, N. Quality of life and the associated psychological factors in caregivers of children with PKU. Iran J Psychiatry 2011;6:66–9.Search in Google Scholar
12. Fidika, A, Salewski, C, Goldbeck, L. Quality of life among parents of children with phenylketonuria (PKU). Health Qual Life Outcomes 2013;11:54. https://doi.org/10.1186/1477-7525-11-54.Search in Google Scholar
13. Liu, N, Kong, XD, Zhao, DH, Wu, QH, Li, XL, Guo, HF, et al. Prenatal diagnosis of Chinese families with phenylketonuria. Genet Mol Res 2015;14:14615–28. https://doi.org/10.4238/2015.november.18.25.Search in Google Scholar
14. Guermazi, M, Allouch, C, Yahia, M, Huissa, TB, Ghorbel, S, Damak, J, et al. Translation in Arabic, adaptation and validation of the SF-36 health survey for use in Tunisia. Ann Phys Rehabil Med 2012;55:388–403. https://doi.org/10.1016/j.rehab.2012.05.003.Search in Google Scholar
15. McHorney, CA, Ware, JEJr., Raczek, AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247–63. https://doi.org/10.1097/00005650-199303000-00006.Search in Google Scholar
16. Garcia, M, Rohlfs, I, Sala, J, Pena, A, Masia, R, Marrugat, J, et al. Comparison between telephone and self-administration of short form health survey questionnaire (SF-36). Gac Sanit 2006;19:433–9.10.1016/S0213-9111(05)71393-5Search in Google Scholar
17. Watson, EK, Firman, DW, Baade, PD, Ring, I. Telephone administration of the SF-36 health survey: validation studies and population norms for adults in Queensland. Aust N Z J Public Health 1996;20:359–63. https://doi.org/10.1111/j.1467-842x.1996.tb01046.x.Search in Google Scholar
18. Lean, ME, Han, TS, Seidell, JC. Impairment of health and quality of life using new US federal guidelines for the identification of obesity. Arch Intern Med 1999;159:837–43. https://doi.org/10.1001/archinte.159.8.837.Search in Google Scholar
19. Younsi, M, Chakroun, M. Measuring health-related quality of life: psychometric evaluation of the Tunisian version of the SF-12 health survey. Qual Life Res 2014;23:2047–54. https://doi.org/10.1007/s11136-014-0641-8.Search in Google Scholar
20. Morfeld, M, Bullinger, M, Nantke, J, Brahler, E. The version 2.0 of the SF-36 health survey: results of a population-representative study. Soz Praventivmed 2005;50:292–300. https://doi.org/10.1007/s00038-005-4090-6.Search in Google Scholar
21. Huber, MB, Felix, J, Vogelmann, M, Leidl, R. Health-related quality of life of the general German population in 2015: results from the EQ-5D-5L. Int J Environ Res Public Health 2017;14. https://doi.org/10.3390/ijerph14040426.Search in Google Scholar
22. Bosch, AM, Burlina, A, Cunningham, A, Bettiol, E, Moreau-Stucker, F, Koledova, E, et al. Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries. Orphanet J Rare Dis 2015;10:80. https://doi.org/10.1186/s13023-015-0294-x.Search in Google Scholar
23. Reilly, C, Taft, C, Nelander, M, Malmgren, K, Olsson, I. Health-related quality of life and emotional well-being in parents of children with epilepsy referred for presurgical evaluation in Sweden. Epilepsy Behav 2015;53:10–4. https://doi.org/10.1016/j.yebeh.2015.09.025.Search in Google Scholar
24. Vasilopoulou, E, Nisbet, J. The quality of life of parents of children with autism spectrum disorder: a systematic review. Res Autism Spectr Disord 2016;23:36–49. https://doi.org/10.1016/j.rasd.2015.11.008.Search in Google Scholar
25. Aras, I, Stevanovic, R, Vlahovic, S, Stevanovic, S, Kolaric, B, Kondic, L. Health related quality of life in parents of children with speech and hearing impairment. Int J Pediatr Otorhinolaryngol 2014;78:323–9. https://doi.org/10.1016/j.ijporl.2013.12.001.Search in Google Scholar
26. Ben Salah Frih, Z, Boudoukhane, S, Jellad, A, Salah, S, Rejeb, N. Quality of life of parents of children with cerebral palsy. J Réadapt Méd 2010;30:18–24. https://doi.org/10.1016/j.jrm.2010.01.001.Search in Google Scholar
27. McStay, RL, Trembath, D, Dissanayake, C. Maternal stress and family quality of life in response to raising a child with autism: from preschool to adolescence. Res Dev Disabil 2014;35:3119–30. https://doi.org/10.1016/j.ridd.2014.07.043.Search in Google Scholar
28. Allik, H, Larsson, JO, Smedje, H. Health-related quality of life in parents of school-age children with Asperger syndrome or high-functioning autism. Health Qual Life Outcomes 2006;4:1. https://doi.org/10.1186/1477-7525-4-1.Search in Google Scholar
29. Kheir, N, Ghoneim, O, Sandridge, AL, Al-Ismail, M, Hayder, S, Al-Rawi, F. Quality of life of caregivers of children with autism in Qatar. Autism 2012;16:293–8. https://doi.org/10.1177/1362361311433648.Search in Google Scholar
30. Montes, G, Halterman, JS. Association of childhood autism spectrum disorders and loss of family income. Pediatrics 2008;121:e821–6. https://doi.org/10.1542/peds.2007-1594.Search in Google Scholar
31. Roach, MA, Orsmond, GI, Barratt, MS. Mothers and fathers of children with Down syndrome: parental stress and involvement in childcare. Am. J. Ment. Retard. 1999;104:422–36. https://doi.org/10.1352/0895-8017(1999)104<0422:mafocw>2.0.co;2.10.1352/0895-8017(1999)104<0422:MAFOCW>2.0.CO;2Search in Google Scholar
32. Dardas, LA, Ahmad, MM. Predictors of quality of life for fathers and mothers of children with autistic disorder. Res Dev Disabil 2014;35:1326–33. https://doi.org/10.1016/j.ridd.2014.03.009.Search in Google Scholar
33. Iakovou, K, Madoglou, A, Monopolis, I, Schulpis, K. The effect of PKU diet on the maternal quality of life and social discrimination in relation to their educational status and place of living. J Pediatr Endocrinol Metab 2019;32:281–5. https://doi.org/10.1515/jpem-2018-0525.Search in Google Scholar
34. Ben Thabet, J, Sallemi, R, Hasiri, I, Zouari, L, Kamoun, F, Zouari, N, et al. Psycho-emotional impact of a child’s disability on parents. Arch Pédiatr 2013;20:9–16. https://doi.org/10.1016/j.arcped.2012.10.024.Search in Google Scholar
35. Hsiao, Y. Pathways to mental health-related quality of life for parents of children with autism spectrum disorder: roles of parental stress, children’s performance, medical support, and neighbor support. Res Autism Spectr Disord 2016;23:122–30. https://doi.org/10.1016/j.rasd.2015.10.008.Search in Google Scholar
36. Lee, GK, Lopata, C, Volker, MA, Thomeer, ML, Nida, RE, Toomey, JA, et al. Health related quality of life of parents of children with high-functioning autism spectrum disorders. Focus Autism Other Dev Disabl 2009;24:227–39. https://doi.org/10.1177/1088357609347371.Search in Google Scholar
37. Bekhet, AK, Johnson, NL, Zauszniewski, JA. Resilience in family members of persons with autism spectrum disorder: a review of the literature. Issues Ment Health Nurs 2012;33:650–6. https://doi.org/10.3109/01612840.2012.671441.Search in Google Scholar
38. Feillet, F. Phenylketonuria. Presse Med 2006;35:502–8. https://doi.org/10.1016/s0755-4982(06)74625-5.Search in Google Scholar
© 2020 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review Articles
- Definition and early diagnosis of metabolic syndrome in children
- Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment
- Original Articles
- Association of sleep characteristics with adiposity markers in children
- Prevalence of abdominal obesity in non-obese adolescents: a North Indian adolescent study
- Utility of estimated glucose disposal rate for predicting metabolic syndrome in children and adolescents with type-1 diabetes
- Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes
- Association between eating behavior, anthropometric and biochemical measurements, and peptide YY (PYY) hormone levels in obese adolescents in outpatient care
- Autoimmune hyperthyroidism in children & adolescents in Sudan: a 13 years’ experience of a Paediatric Endocrinology Clinic
- Timing, prevalence, and dynamics of thyroid disorders in children and adolescents affected with Down syndrome
- Assessment of the most common CYP21A2 point mutations in a cohort of congenital adrenal hyperplasia patients from Egypt
- Quality of life and associated factors in parents of children with late diagnosed phenylketonuria. A cross sectional study in a developing country (Tunisia)
- Genetic analysis and long-term treatment monitoring of 11 children with glycogen storage disease type IIIa
- Growth and metabolic effects of long-term recombinant human growth hormone (rhGH) treatment in short children born small for gestational age: GH-RAST study
- Menstrual cycle, reproductive function, body mass index, and metabolic profiles of women with former central precocious puberty: 10–20-year longitudinal cohort study in southern Thailand
- Letter to the Editors
- European Society of Paediatric Radiology (ESPR) Child Abuse Taskforce Committee: a response to Miller et al.
- The correct formula to calculate triglyceride-glucose index (TyG)
- Case Reports
- Octreotide-related exocrine pancreatic insufficiency (EPI) in congenital hyperinsulinism
- Improvement in glycaemic parameters using SGLT-2 inhibitor and GLP-1 agonist in combination in an adolescent with diabetes mellitus and Prader-Willi syndrome: a case report
- Three patients with glucose-6 phosphatase catalytic subunit 3 deficiency
- Efficacy and safety of denosumab treatment in a prepubertal patient with cherubism
Articles in the same Issue
- Frontmatter
- Review Articles
- Definition and early diagnosis of metabolic syndrome in children
- Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment
- Original Articles
- Association of sleep characteristics with adiposity markers in children
- Prevalence of abdominal obesity in non-obese adolescents: a North Indian adolescent study
- Utility of estimated glucose disposal rate for predicting metabolic syndrome in children and adolescents with type-1 diabetes
- Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes
- Association between eating behavior, anthropometric and biochemical measurements, and peptide YY (PYY) hormone levels in obese adolescents in outpatient care
- Autoimmune hyperthyroidism in children & adolescents in Sudan: a 13 years’ experience of a Paediatric Endocrinology Clinic
- Timing, prevalence, and dynamics of thyroid disorders in children and adolescents affected with Down syndrome
- Assessment of the most common CYP21A2 point mutations in a cohort of congenital adrenal hyperplasia patients from Egypt
- Quality of life and associated factors in parents of children with late diagnosed phenylketonuria. A cross sectional study in a developing country (Tunisia)
- Genetic analysis and long-term treatment monitoring of 11 children with glycogen storage disease type IIIa
- Growth and metabolic effects of long-term recombinant human growth hormone (rhGH) treatment in short children born small for gestational age: GH-RAST study
- Menstrual cycle, reproductive function, body mass index, and metabolic profiles of women with former central precocious puberty: 10–20-year longitudinal cohort study in southern Thailand
- Letter to the Editors
- European Society of Paediatric Radiology (ESPR) Child Abuse Taskforce Committee: a response to Miller et al.
- The correct formula to calculate triglyceride-glucose index (TyG)
- Case Reports
- Octreotide-related exocrine pancreatic insufficiency (EPI) in congenital hyperinsulinism
- Improvement in glycaemic parameters using SGLT-2 inhibitor and GLP-1 agonist in combination in an adolescent with diabetes mellitus and Prader-Willi syndrome: a case report
- Three patients with glucose-6 phosphatase catalytic subunit 3 deficiency
- Efficacy and safety of denosumab treatment in a prepubertal patient with cherubism